Physician profile
Lisa Odom
NPI 1598007668
$568.56
in general payments reported to CMS, 2019-2025
16 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.64 · 2020: $47.68 · 2021: $121 · 2022: $90.26 · 2023: $41.50 · 2024: $65.21 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.50 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $155.39 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Sanofi Pasteur INC. | $65.19 | 2022-2023 | |
| Abbvie INC. | $56.72 | 2021-2023 | |
| Supernus Pharmaceuticals, INC. | $41.75 | 2022-2024 | Qelbree |
| Merck Sharp & Dohme LLC | $40.56 | 2022-2025 | Capvaxive, Gardasil 9 |
| Edwards Lifesciences Corporation | $25.09 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Almatica Pharma LLC | $21.71 | 2021 | |
| Kyowa Kirin, INC. | $21.03 | 2025 | |
| Sanofi-Aventis U.S. LLC | $20.01 | 2025 | |
| Ibsa Pharma INC. | $19.31 | 2024 | Flector, Licart, Tirosint |
| Insulet Corporation | $19.06 | 2024 | Omnipod |
| Ironshore Pharmaceuticals INC. | $18.75 | 2021 | |
| Amgen INC. | $16.64 | 2019 | |
| Therapeuticsmd, INC. | $16.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.67 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Odom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.